October 19, 2023 02:15 PM EDT
Deals
Pharma

PTC to sell roy­al­ties on block­buster SMA drug Evrys­di for up to $1.5B

Lia DeGroot

PTC Ther­a­peu­tics on Thurs­day an­nounced an agree­ment with Roy­al­ty Phar­ma to mon­e­tize up to $1.5 bil­lion of the roy­al­ty stream for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Sage sues Bio­gen days af­ter $469M buy­out of­fer

FDA ap­proves As­traZeneca and Dai­ichi Sankyo’s ADC for breast can­cer de­spite lack of sur­vival ben­e­fit

Ozem­pic makes list for next round of Medicare drug price ne­go­ti­a­tions

Roche's car­diometa­bol­ic chief warns against weight loss 'ob­ses­sion' with GLP-1s

What Trump's CMS can and can't change with the sec­ond round of drug price ne­go­ti­a­tions

A mixed year for deals and dol­lars left biotech ex­ecs hun­gry for a bet­ter 2025

A service from the Financial Times